MCI-154, a novel cardiotonic agent, reverses the acidic pH-induced decrease in responses of cardiac myofilaments to Ca++: comparison with sulmazole and pimobendan.

Source:http://linkedlifedata.com/resource/pubmed/id/2033522

Download in:

View as

General Info

PMID
2033522